Yesterday, as long anticipated, the Food and Drug Administration (FDA) approved GW Pharmaceutical’s Epidiolex, a cannabidiol (CBD) oral solution for the treatment of seizures associated with two forms of epilepsy.
In an historic resolution, the World Health Organization (WHO) Expert Committee on Drug Dependence just recommended that “preparations considered to be pure CBD should not be scheduled within the International Drug Control Conventions.”
Some key findings from the WHO:
Full reports from the WHO conference in Geneva can be found here.
The WHO confirms what we’ve been saying all along: CBD should not be treated as a controlled substance. Passage of the 2018 Farm Bill with the Senate’s pro-hemp language will ensure the full legalization of hemp extracts, cannabinoids and derivatives such as hemp-derived CBD. Please send an email today to your Members of Congress to urge them to permanently legalize hemp and hemp-derived CBD.